My underlying reason for performing this Mid 2023 Investment Holdings Review based on June 30, 2023 closing stock prices is that I hold shares in several investment accounts. Undertaking an Investment Holdings Review enables me to get a better picture of my exposure to each holding. I last completed such a review on January 31, [...]
This FFJ Portfolio - June 2023 report is an overview of my recent investment activity. The value of the holdings within the FFJ Portfolio has increased by ~$61,913 CDN and ~$976,431 USD relative to June 2022. The increase is attributed to my concerted effort to increase my exposure to high-quality US companies. Secondly, the share [...]
I consider low-risk Paychex (PAYX) to currently be attractively valued. I last reviewed this holding in my March 30, 2023 post at which time Q3 and YTD2023 results had just been released. With the release of its Q4 and FY2023 results and FY2024 outlook, I briefly revisit this holding. Business Overview Although I provide a [...]
I last reviewed Nasdaq, Inc. (NDAQ) in this October 21, 2021 post. Based on my analysis, I decided not to initiate a position. Fast forward to June 12, 2023. NDAQ has announced that it entered into a definitive agreement to acquire Adenza from Thoma Bravo for $10.5B in cash and shares of common stock; Adenza [...]
My Mastercard Is A Compelling Investment guest post at Dividend Power touches upon why it, and Visa (V), are my two largest holdings. While both Mastercard (MA) and V have been mandated by various jurisdictions to cap their interchange fees, I do not consider this as a reason to sour on either company; interchange fees [...]
Intact Financial (IFC.to) has attractive Total Shareholder Return (TSR) potential; it generated a ~14% Total Shareholder Return (TSR) from 2012 - 2022. While past results have no bearing on future results, IFC is a well-managed insurance company which leads me to believe it has a reasonable probability of generating a comparable return over the next [...]
This FFJ Portfolio - May 2023 report is an overview of my recent investment activity. The month of May was interesting. The risk of failure in the US debt ceiling negotiations contributed to weakness in the share price of many companies. This is borne out by the monthly variance in the total value of the [...]
I last reviewed Automatic Data Processing (ADP) in my January 26 post. Based on my analysis, I added a few additional shares at ~$225 in a retirement account where most of my ADP exposure is held; I do not disclose retirement account details. This explains why ADP was my 15th largest holding when I [...]
In my May 23 HEICO Corporation's (HEI and HEI.a) post, I disclose the purchase of 200 Class A non-voting shares @ ~$132/share. Upon further reflection, I have increased my HEICO exposure in the FFJ Portfolio with the purchase of another 100 shares at ~$127/share on May 26. This brings my exposure to 400 shares [...]
In this May 19, 2023 post, I disclose a new position in Thermo Fisher Scientific (TMO) with the purchase of 52 shares @ ~$515; I hold these shares in a 'Core' account within the FFJ Portfolio. On May 24, TMO held its 2023 Investor Day. Based on the information presented I acquired an additional [...]
